Floatz logo

Eliglustat

Colorectal Cancer

Chinese PLA General HospitalSmall moleculePhase 2Active
CC
46/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
59/ 100

Competitive context

713 Active assets in the Colorectal Cancer cohort.

Asset / SponsorPhaseRating
Desflurane
Peter MacCallum Cancer Centre, Australia
Phase 4BBB
MARBLE DUST
James Varani
Phase 2/3BB
Orectalip
Sinphar Pharmaceutical Co., Ltd
Phase 4BB
FLUOROURACILUM
UNICANCER
Phase 4BB
Levofolinic Acid
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 3BB

View all 50 →

Same molecule, other indications

Eliglustat is also rated in:

Gaucher diseaseActive
BBB
Indicative · Phase 3
76 / 100
View asset →
Gaucher disease type IIIActive
BB
Indicative · Phase 3
64 / 100
View asset →
Gaucher disease type IDormant
B
Indicative · Phase 2
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →